Form 4: Texas Instruments CFO Executes Stock Option Exercise
Statement of Changes in Beneficial Ownership
Texas Instruments CFO Rafael R. Lizardi exercised options for 40,541 shares and subsequently sold 40,541 shares.
Summary
- Rafael R. Lizardi, Senior Vice President and CFO of Texas Instruments, exercised stock options for 40,541 shares at a strike price of $169.23.
- Following the exercise, the CFO sold the entire block of 40,541 shares in three separate transactions.
- The sales occurred at weighted average prices ranging from $273.74 to $275.53 per share.
- Post-transaction, the reporting person maintains direct ownership of 85,485 shares of common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as it represents routine insider liquidity management rather than a strategic shift or signal of financial distress.
Positives
- The executive maintains a significant remaining direct equity stake of 85,485 shares, signaling continued alignment with shareholder interests.
Negatives
- The transaction represents a complete liquidation of the specific option grant exercised, resulting in a net reduction of potential future equity accumulation from this specific tranche.
Risks
- Market volatility could impact the value of the remaining 85,485 shares held by the executive.
Future Outlook
No specific forward-looking guidance regarding company operations was provided in this filing.
Industry Context
StockSavvy.ai notes that executive stock sales are common occurrences for liquidity and tax planning purposes and do not necessarily reflect a change in the executive's outlook on the company's long-term performance.
Comparison to Industry Standards
- The exercise and sell strategy is consistent with standard executive compensation and liquidity management practices observed at large-cap semiconductor firms like Intel, Analog Devices, and Qualcomm.
Stakeholder Impact
- Minimal impact on shareholders as the transaction was executed at market prices and represents a standard exercise of vested equity compensation.
Next Steps
- No future actions or milestones were disclosed in this filing.
Key Dates
| Date | Description |
|---|---|
| 04/24/2026 | Date of option exercise and subsequent sale of common stock. |
| 04/27/2026 | Date of filing for the reported transactions. |
Keywords
Texas Instruments, TXN, Insider Trading, Form 4, CFO, Stock Options
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.